Hello readers. In listening to some of the podcasts out there, and reviewing some of these charts it seems that we may be in for a substantial correction in the Nasdaq and Dow in the future (who knows when maybe not). I mainly buy blue chip and some biotech/tech stocks for fun that I see […]
Articles
- Most Relevant
- Most Recent
and put many electric buyers out of business.Thanks Travis
It is supposed to with over 3 Trillion dollars over 7 to 8 years, that is possibly blockchain technology.Thanks Travis
Anyone know what this is: “Dr. Mark Skousen here. Today, I’m going to show you how to retire on a single stock… My “Alpha-Gold” investment. By this time next year, you could be enjoying 10X… 20X… even 30X your money. But only if you get into it now, before the gold rush really takes off. […]
Nick Giambruno is helming the Crisis Investing letter for Casey Research now, which must come with a fairly high degree of attention because Doug Casey really made his name with his bestselling book of the same name in the late 1970s (later revised a couple times). And after all this time you know what you’re […]
I have no idea what’s going to happen in the market today, but perhaps if I spend my time looking into a teaser pitch from a new newsletter I’ll be too busy to obsess over my portfolio and do something dumb during the trade war panic gyrations. Sound good? Want to join me? Great! The […]
Finally, we take a short break from the A.I. mania to look at something else… this is the start of the pitch from Stansberry for Dr. David Eifrig’s Prosperity Investor(special deal is $2,500 for two years), with the ad introduced by Thomas Carroll, one of the analysts for that letter (John Engel is the other, […]
Dr. David Eifrig has usually one of the more sober pitchmen at Stansberry (odd choice of words for a guy who owns a winery, I guess), and his Retirement Millionaire newsletter (usually sold at $49/yr, renews at $199) is probably his most conservative product — offering up “retirement living” lifestyle advice as well as what […]
This article was originally published on August 4, 2022, but Ray Blanco has lately been pitching it as an urgent “last chance” idea because of their March 20, 2023 announcement, so we’re re-sharing this older article so folks can at least know what company he’s talking about (the preclinical results they announced at a conference […]
This article originally ran on January 8, 2013. It has not been updated save for the addition of this brief introductory note. More recent ad pitches on this same topic that say the stock and ticker have been “hacked” probably refer to our coverage of the story, but the more recent ads do not appear […]
Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]
There’s a clear winner in the “what readers are asking about” sweepstakes this morning, and it’s the latest pitch from Charles Mizrahi for his Park Avenue Investment Club (currently $99/yr) — so that ad must really be making the rounds, and we’ll fire up the Thinkolator to get you some answers today. The pitch is […]
[ed note: Doc Gumshoe is our favorite medical writer, and he usually pops in to explore a topic or answer questions readers have posed a couple times a month — he’s not a medical doctor and, as always, his opinions are his own.] Let’s start this off with a hypothetical case, or rather, three hypothetical […]
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
This discussion came about as the result of the GS thread ”This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug” It is hoped that all/any that can throw light, can brainstorm here and feedback consensus to the thread. Good work Guys. my best Alan Harris.
What started me down this path was a promotional piece for a new drug that was purported to suppress pain through a novel mechanism that prevented the nerve signal that conveyed to the brain a sensation that would usually be experienced as painful from actually being painful. In other words, while mincing an onion, you […]
DISCLAIMER: I am long shares of SBOTF and may add to the position at any time. ”Even blind squirrels find an acorn every now and then” OK, I know .. there is already plenty of discussion re Stellar Biotechnologies (SBOTF) on the site. Since Travis posted the tease from Nick Hodge in early July, the […]
The first version of this story was published on July 28, 2016 under the headline Palm Beach: “Issuing a strong ‘buy’ recommendation for ‘the next Bitcoin.’” Tom Dyson, Teeka Tiwari’s publisher at Palm Beach, has a new pitch out for these cryptocurrencies, which he calls “Bit Shares,” again touting Ethereum and Bitcoin but also adding […]
Crypto stories are running hot and heavy once again, as Bitcoin and Ethereum have staked out dramatic new highs in recent months… and whenever that happens in a sector, we know the newsletter sales pitches will follow. I covered one of those in the Friday File last week from the Oxford Club folks, and today […]
We’ll start the week out with a teaser pitch I’ve been seeing from Jason Stutman for his Technology & Opportunity newsletter. As with so many stocks that are hinted at, this one plucks at our greed-strings via comparison with a massive success story — this time it’s Netflix, as Stutman refers to his “secret” pick […]
Our old friend and teaser adversary Louis Navellier hasn’t been spinning so many teasers lately — I like to think he’s terrified of the Stock Gumshoe, and of the way that my brilliant, amusing, and awe-inspiring commentaries tear his teasers to shreds and lay waste to his marketing efforts. Sure, it’s a fantasy, but we […]
Most of the newsletter ads I see come pouring in through the email floodgates, but there are still a few publishers who invest in good ‘ol direct mail campaigns and send you actual letters in the mail — they realize, no dummies, that most of their potential customers are old enough that they might even […]
“Tulane University Confirms Medical Breakthrough: “Tiny Biotech Unveils ‘Single Shot’ Cure for Heart Disease “The news could go public any day… and this small San Diego-based company will instantly dominate a $305 BILLION market. “Investors who act now could book gains of 9,275%… “ Now THAT’S what I want to hear — looking at gold […]
I was getting ready to write about Lee Lowell’s put-selling strategy, but then this ad crossed my screen a bunch of times in a matter of moments … and I do love when we “learn” about secret share classes, disappearing stocks, and wacky ticker symbols, so I thought I should check it out for you. […]
“To secure your chance at wealth you’ve only dreamed of, you must act BEFORE the NEXT shocking event, scheduled for Wednesday, September 23. “That’s when the rest of the world will learn what you’ll know just seconds from now… “We’re in the final warm-up laps now — the CEO’s news release I’ll tell you all […]
Bitterness over the financial bailouts seems to have waned a bit, but there’s certainly a strong vein of anger to mine … and that’s exactly what copywriters are paid to do. This time, it’s in an ad for Jim Nelson’s Lifetime Income Report — and this is the investment idea he’s got for you: “This […]
This article was originally published on the members-only Irregulars site on July 31, 2009, it is being reproduced here but has not been updated or significantly revised. Now that Matt Badiali’s S&A Oil Report has renamed itself the S&A Resource Report, it shouldn’t be any surprise that he’s looking not just at the energy companies […]
Since the Stock Gumshoe’s vacation hiatus is just about to begin this morning, I thought I’d share a quick bonus for those of you who are not yet members of the Stock Gumshoe Irregulars — this article first appeared in the Irregulars Friday File on July 10, and it has not been updated. Daily articles […]
“A Market Insider and Lifelong Friend Hands Me the Best Opportunity of 2009 “‘I can’t imagine a better stock to buy.’” That’s how the newest ad launches for Porter Stansberry’s Inside Strategist, a newsletter that has churned through at least two editors in the last few years, but which is now apparently run by Porter […]
This tease comes in an ad for the Motley Fool’s Global Gains newsletter, which has brought some interesting ideas to our attention during its relatively short life so far (though I imagine it probably had a terrible year last year — this is one of the few Motley Fool newsletters that Hulbert doesn’t track, and […]
This ad sounds a little bit like a very popular one we looked at a few months back — then, it was for $1 “Silver Shots”, and it was a teaser for a leveraged derivative trade on silver futures (or, in plainer speak, it was for long-term call options on the SLV ETF). If you […]
Brazil’s economy is finally growing now, a growth that it started getting credit for a few years ago, before the expansion really started — five years ago, it was enough that Brazil under President Lula seemed to have a handle on inflation and a reasonably pro-business government. Now, it’s one of the few large, stable […]
Brazil’s economy is finally growing now, a growth that it started getting credit for a few years ago, before the expansion really started — five years ago, it was enough that Brazil under President Lula seemed to have a handle on inflation and a reasonably pro-business government. Now, it’s one of the few large, stable […]
As I type this I’m waiting for the deliveryman to arrive, bringing my new router and computer — one thing I can say about life as the Stock Gumshoe, it’s hell on my laptop. The poor thing is so clogged with spam and has been sent on so many forced marches across the internet as […]
As I type this I’m waiting for the deliveryman to arrive, bringing my new router and computer — one thing I can say about life as the Stock Gumshoe, it’s hell on my laptop. The poor thing is so clogged with spam and has been sent on so many forced marches across the internet as […]
I’m sure many of you have seen the “Alpha Bulldogs” ad for Martin Hutchinson’s Permanent Wealth Investor newsletter — the marketing for this one is everywhere, and the ad letters are filled with promise for those who need some income and safety. Hutchinson claims that he only recommends “Alpha Bulldogs that are already legally required […]
The Money Map folks are currently selling their subscription service by offering to throw in a free copy of Peter Schiff’s Crash Proof … the book is a couple years old now, and will be updated by a new version this Fall, but they tease a few of the investment ideas Schiff focuses on — […]
This ad has been crashing in on Gumshoe beach in massive waves over the last week, so I thought it might be time to take a gander. It’s for the Xcelerated Profits report at Mt. Vernon Research — the last time I saw a similar ad it was from Karim Rahemtulla for this same report, […]
OK, so let me just warn you up front: The latest ad from Nancy Zambell for her new Buried Treasure under $10 newsletter has a lot of, well, hooey in it. But really, doesn’t that just make it more fun? Here’s how the hype begins: “Buffett has sunk $2 billion into the next Wal-Mart Here’s […]
One of the introductions to this ad reads thus: “Use this code: CKUCU. “If you go to your brokerage account today… type in stock ticker COF… and enter the code’s 5 letters – you’ll receive $920 within 5 minutes.” But the more fun introduction, the one that’s probably really getting peoples’ attention, is this: “Use […]